Comparison of the effectiveness of two medicines namely Methotrexate and Apremilast in patients with a skin disease called psoriasis
Phase 4
- Conditions
- Health Condition 1: L400- Psoriasis vulgaris
- Registration Number
- CTRI/2019/04/018854
- Lead Sponsor
- Yenepoya Medical College
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
•All patients visiting the Dermatology OPD diagnosed to have Psoriasis who needs systemic therapy.
•Patients requiring and willing to undergo treatment with Methotrexate or Apremilast
Exclusion Criteria
1.Patients who have taken systemic therapy in past three months or topical treatment or phototherapy in past 2 weeks
2.Who are lesser than 18 years of age.
3.Pregnant or those having any serious illness contraindicating systemic therapy.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method